Hemogenyx Pharmaceuticals Plc (HEMO.L)
Develops blood cancer treatments using engineered immune cells and antibodies.
669.75-0.04%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+334.2%
The outlook
Hemogenyx Pharmaceuticals trades well below its 50- and 200-day moving averages, sitting in the lower third of its 52-week range. Analyst coverage appears thin. The overall sentiment currently leans bearish based on available market signals.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range32% of the way from its 52-week low to high
Market cap
$45.5M
52-wk high
1,800.00
52-wk low
130.00
50-day avg
753.11
200-day avg
797.41
Trailing P/E
—